Royal Philips is focused on improving people’s lives through meaningful innovation in health and well-being. As a global leader in providing solutions for health care, the needs of the patient are central to everything we do. By pioneering new solutions that improve and expand care around the world, we are dedicated to creating the ideal experience for all patients, young and old. Handheld Diagnostics is a dedicated business that focuses on developing innovative In-Vitro Diagnostics solutions to revolutionize Point-of-Care testing.
Philips brings in specific knowledge regarding the magnetic labeling technology (Magnotech) which is required to measure and produce a lab-quality Point-of-Care test, like cardiac Troponin-I. This test has been developed with the help and input of various industrial partners.
Furthermore Philips has a long track record in building medical equipment and health care IT, which can be utilized to provide data communication between the Point-of-Care device and the Hospital Information System. Philips acts as a system integrator of the total solution including assay, cartridge, software and analyzer.
Jos Rijntjes, PhD
Jos Rijntjes studied Biology and obtained his PhD in molecular biology with a thesis on Hepatitis B infection and has a long track record in the in-vitro diagnostics (IVD) business. Jos joined Philips in September 2006, where his first task was to develop a roadmap for handheld (biosensor) diagnostic systems. Before joining Philips, he worked for a leading biotech company in the field of DNA- and RNA-based molecular diagnostics as Chief Commercial Officer and a Member of the Board.
Prior to that, he worked for several leading Diagnostics companies in a range of functions including Senior Research Leader, Project Leader, Program Manager, International Marketing Manager and Sales Manager. Jos has been leading several multi-national and multi-company IVD R&D-projects in the past as Program Manager.
Femke de Theije, PhD
Femke de Theije is a technical expert for Point-of-Care immunoassay development, experienced in R&D at the interface of point-of-care immunoassays and the biosensor system, and the analytical and clinical evaluation of biomarkers on the biosensor system. Femke is heading the group of Assay Development and Process Development Engineers in the Philips Handheld Diagnostics Venture. She has a MSc degree in Chemistry and a PhD in Surface Chemistry, and over 12 years of experience within Philips R&D, of which 7 years in the Philips Handheld Diagnostics Venture.
Veronique Semjonow, M.D.
Veronique Semjonow is a fully qualified Medical Doctor with more than twenty year of experience in IVD in the field of endocrinology, cardiovascular disease, oncology, prenatal care and anemia, both in scientific and clinical settings. Veronique has a very strong background in immunoassay technology, laboratory testing, clinical operations, clinical trials, medical affairs networking, market development and international marketing. During her career, she has also held positions in scientific organizations such as the American College of Cardiology, European Thyroid Association, European Group on Tumor Markers (Secretary), European Randomized Study on Screening for Prostate Cancer, IFCC Scientific Division Working Groups, and the International Collaborative for Standardization of hGH Assays.
Henk Peels (Study coordinator)
Henk Peels studied Microbiology. He worked for several large Diagnostic companies in functions ranging from explorative research, product development, product validation, system engineering, system integration and Human Factor engineering in the fields of Immuno- and Nucleic acid assays, instruments and software products. Henk has over 20 year experience in the In-Vitro diagnostics industry with an affinity for Human Factor Engineering User Interfaces and Usability validation. And over 10 year of experience in Project Management with an affinity for communication and multi disciplinary, multi cultural teams.